Join us on the Sun Pharma Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock.
Sun Pharmaceutical Industries targets mid- to high-single digit topline growth in FY26, focusing on innovative medicines and ...
Sun Pharma Dividend 2025: Sun Pharma, the pharma company, is set to trade ex-date and record date on February 6, 2025. The state-run company announced a 1,050 per cent dividend payment on each stock ...
The US-Venezuela tensions has turned the spotlight on shares of companies like Indian Oil Corp, Oil India, Sun Pharma, Dr ...
PRINCETON, N.J., Oct. 22, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma ...
Taro Pharmaceutical Industries, a unit of Sun Pharma, is recalling over 17,000 units of an antifungal medication in the US ...
Sun Pharma highlights obesity treatment drugs as a growth driver for India's pharma industry, enhancing access to GLP-1 ...
Sun Pharmaceutical Industries Inc. (Sun Pharma), the fourth largest specialty generic pharmaceutical company globally, is offering a summer internship program in 2025 for students to gain practical ...
A revolution in India’s weight-loss market is coming. As Semaglutide’s patent ends in 2026, Sun Pharma, Lupin, Torrent, and ...
Sun Pharma-owned Taro Pharmaceutical is recalling over 17,000 units of antifungal Ciclopirox Shampoo in the US due to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results